Kerecis to Present Evidence on Superiority of Fish-Skin Treatment at the Symposium on Advanced Wound Care

Attendees are learning how fish-skin grafts outperform standard care through scientific sessions, a hands-on workshop and 50 poster presentations

LAS VEGAS--(BUSINESS WIRE)--Kerecis, the pioneer in the use of fish-skin and fatty acids for tissue regeneration and protection, is a high-profile participant and presenter at this year’s Symposium on Advanced Wound Care (SAWC). Attendees are discovering the significant science supporting fish-skin graft’s superior ability to treat difficult-to-close wounds and accelerate recovery. SAWC is currently taking place in Las Vegas through October 5, 2024. The Kerecis booth is number 517.

Kerecis will release an important announcement regarding exciting new research tomorrow, October 4, 2024.

Kerecis is educating SAWC participants on remarkable fish-skin graft results

Excitement is mounting about the use of fish-skin grafts for advanced wound care. Kerecis is teaching SAWC participants about the groundbreaking science in several ways:

• An industry-supported session taking a deep dive into the use of fish skin for the treatment of diabetic foot ulcers with exposed structures. The focus is on new research bringing hope to patients at high risk of complications and amputations. The session will take place Friday, October 4, 2024 from 11:30 a.m. to 12:30 p.m. in the Milano VII-VIII room at Caesars Palace.
• During a hands-on skills lab, entitled: Overcoming Challenges in Assessing and Managing Lower Extremity Wounds: Hands-On Workshop, Kerecis medical affairs program managers and Michael Lacqua, MD will demonstrate Kerecis products, highlighting advanced applications in real-world clinical settings. The skills lab will take place Thursday, October 3rd, from 1:20 p.m. to 4:40 p.m. in Augustus I.
• The “Taste of Iceland” event will allow participants to explore Icelandic culture and its connection with Kerecis innovations. This popular event will take place Friday, October 4th, from 4:00 p.m. to 6:00 p.m. in Neopolitan IV – Promenade level.
• Additionally, 50 posters will detail advancements and case studies involving Kerecis products. The abstracts will be presented on Friday, October 4, from 6:15 p.m. to 7:30 p.m. in Augustus 3.

Healthcare providers specializing in wound care, podiatry, and diabetic foot care are encouraged to visit www.kerecis.com/publication to learn more about the groundbreaking science and the potential of fish-skin grafts for advanced wound care.

Media Note: For additional information or to schedule an interview, contact the Media Relations Agency at [phone].

About Kerecis

Kerecis, founded by Fertram Sigurjonsson, develops fish-skin and fatty acid products for cellular therapy, tissue regeneration, and protection. The patented material supports healing and regeneration when grafted onto damaged tissue, with no disease-transfer risk between cold-water fish and humans. The fish-skin is gently processed to maintain its natural structure, strength, and molecules. Clinical studies show that Kerecis products heal wounds faster than competitors. Kerecis is the only global manufacturer of medical devices containing intact fish-skin and is the fastest growing company in the U.S. biologics skin market. Products include SurgiBind®, GraftGuide®, MariGen®, and Shield™ for various medical applications. Committed to the UN Sustainable Development Goals, Kerecis uses sustainable Icelandic fish processed with renewable energy. Kerecis is a part of Coloplast, a leading supplier of intimate healthcare products. For more information, visit https://www.kerecis.com.

Trademarks and registered trademarks are the property of their respective owners.